Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia

Kenya on Thursday launched a national malaria campaign to encourage Kenyans to sleep under insecticide-treated nets (ITNs) every night to prevent infection, the Daily Nation reports.

Elizabeth Juma, head of Kenya's Division of Malaria Control, said, "Though mosquito net ownership has increased, their actual use remains relatively low." According to the Daily Nation, "recent statistics reveal that only 48 percent of Kenyans slept under nets every night compared to 56 percent who owned them."

Assistant Minister for Public Health James Gesami said that about 18 million ITNs had been distributed, which led to a 44 percent decline in malaria mortality cases of children younger than age of five. The campaign is sponsored by Population Services International in collaboration with the government, the WHO and other medical research organizations (Wanja, 8/27).

Also, PBS' the NewsHour recently aired a segment examining the emergence of drug-resistant malaria in Cambodia. According to the NewsHour, counterfeit drugs and incomplete drug regimens have contributed to the problem. "Taking less than a full dose means some parasites remain in the body, where they adapt genetically and become immune to the drug," NewsHour special correspondent Fred de Sam Lazaro said.

During the show, de Sam Lazaro interviews Mark Fukuda of the U.S. Army, who co-authored a study about drug-resistance in Cambodia. The show also examines how drug-resistant malaria parasites can spread to other regions and discusses Cambodia's efforts to crack down on the distribution of counterfeit drugs. It includes an interview with Michael O'Leary, head of the WHO's Cambodia office (de Sam Lazaro, 8/25).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug MED6-189 shows promise against drug-resistant malaria